Updated OIG Compliance Guidance for Medicare Advantage Programs
The U.S. Department of Health and Human Services Office of Inspector General (OIG) has issued updated compliance guidance for the Medicare Advantage program, enhancing its February 2026 Industry Segment-Specific Compliance Program Guidance (ICPG). Building on the General Compliance Program Guidance (GCPG) from November 2023, this update targets compliance challenges faced by Medicare Advantage Organizations (MAOs) and outlines the compliance duties and risks for healthcare providers involved in Medicare Advantage arrangements.
For physician practices, this guidance is crucial as it identifies potential enforcement actions related to participation in Medicare Advantage plans. The OIG highlights the importance of provider documentation in the risk adjustment process, with diagnoses reported by MAOs to the Centers for Medicare & Medicaid Services (CMS) influencing the higher payments offered for enrollees with elevated risk scores.
The guidance underscores OIG’s focus on enforcing compliance regarding risk adjustment and diagnosis practices. A particular concern is the potential for healthcare providers to submit unsupported or irrelevant diagnoses, which could inaccurately boost an enrollee's risk score, thereby affecting Medicare Advantage payments.
OIG has expressed concerns about electronic medical record prompts and software tools that might inadvertently encourage the entry of incorrect diagnosis codes. Such practices could lead to investigations and penalties, underscoring the need for precise documentation by physicians involved in Medicare Advantage.
The impact of artificial intelligence (AI) on compliance is also a focal point in the guidance. The OIG points out the risks associated with AI-generated prompts and algorithms in risk adjustment and utilization management. The potential for AI to lead to the addition of inaccurate diagnosis codes necessitates robust governance processes for those utilizing AI technologies.
The guidance emphasizes the oversight responsibility of First Tier, Downstream, and Related Entities (FDRs) within Medicare Advantage plans, including physician organizations. If these entities fail to comply with program requirements, the MAO may face accountability from CMS. Enhanced oversight through audits and compliance attestations is strongly encouraged.
Physician practices are advised to review and enhance their compliance infrastructure to meet evolving expectations. By proactively identifying potential risk areas, practices can prepare for increased scrutiny and enforcement actions related to Medicare Advantage. This guidance offers a strategic framework for physician groups engaged in risk-sharing arrangements, diagnosis capture initiatives, and value-based care models, helping them navigate likely regulatory focus in upcoming audits and investigations.